✦ LIBER ✦

Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial

✍ Scribed by Jorge A. Garcia; Tarek Mekhail; Paul Elson; Pierre Triozzi; Cheryl Nemec; Robert Dreicer; Ronald M. Bukowski; Brian I Rini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multinational phase II trial of bevaci

✍ Melichar, B.; Bracarda, S.; Matveev, V.; Alekseev, B.; Ivanov, S.; Zyryanov, A.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 191 KB

Sequential administration of interferon

✍ Manuela Schmidinger; Günther G. Steger; Catharina Wenzel; Gottfried J. Locker; T 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 111 KB

A phase I/II trial with chimeric monoclo

✍ I. Bleumer; J. Beck; Oosterwijk; C. Mala; S. Ullrich; P.F.A. Mulders 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Subcutaneous low-dose recombinant interl

✍ Gaston, R; Oskam, R; Philip, T; Ravaud, A; Négrier, S; Cany, L; Merrouche, Y; Le 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 876 KB

Perioperative immunomodulation with inte

✍ Ornstein, D.K.; Finley, D.S. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 57 KB

A phase-II study of low-dose cyclophosph

✍ Albrecht Lindemann; Klaus Höffken; Reinhold E. Schmidt; Volker Diehl; Otto Kloke 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 937 KB